I want to start with three men. They are composites, so the details are intentionally blurred. But the pattern is real.

The first man had already tried Cialis. Good cardiovascular health. No obvious blood-flow problem. It barely helped. The reflex is to push the dose or switch to another version of the same drug.

We did not start there.

The question was simpler: was there a signal for the drug to amplify? In his case, the machinery was waiting. The wanting was not there. More amplifier does not fix an absent signal.

The second man had the opposite-looking problem. He had been on testosterone for years. The number looked excellent. His libido still did not come back. That tells you the number was not the whole problem. His desire circuit had never really been assessed, and his estradiol had been pushed too low in the attempt to "control estrogen."

So the fuel looked fixed. The engine was still dark.

The third man lost libido while a GLP-1 medication was working well for his metabolic health. That side effect was real. But stopping a medication that was helping his weight, insulin signal, and cardiovascular risk would have been the wrong first move. The better question was: what changed when the weight started moving?

Same complaint on the surface. Three different systems underneath. Treat them the same and you hand people stronger versions of drugs that were never aimed at the break.

The Short Script

Most sexual-health visits start with a short script.

Low libido: check testosterone.

Erection problem: try Cialis or Viagra.

If that does not work, the next move is usually more of the same: a higher dose, a different pill, a different delivery method.

Sometimes that is exactly right. If the blood-flow system is the problem, a blood-flow drug is a good tool.

But if the problem is upstream, the script fails. The drug may be perfectly good. It is just pointed at the wrong layer.

That is not rare. PDE5 inhibitors, the class that includes Cialis and Viagra, do not produce a meaningful response in about 30 to 35 percent of men who take them. Testosterone replacement has the same trap in a different direction: even when the number lands in range, the average improvement in desire is small. A normal testosterone number and a working libido are not the same finding.

The reason is simple. Sexual function is not one system. It is several systems working together: wanting, hormones, reward chemistry, blood flow, metabolism, cellular energy, sleep. When it breaks, the location of the break matters.

Want And Can

Pause there, because this is the fork.

There is the system that makes a person want sex: desire, the pull toward it.

There is another system that makes the body physically respond: blood flow, erection, the ability side.

Want and can. Different circuits. Different signals.

The blood-flow drugs work on the can side. They take an arousal signal that already exists and make the vascular response stronger and longer. If the signal is not there, there is nothing to amplify.

That is why "Cialis did not work" is almost never a reason for more Cialis. It is a reason to ask which system is broken.

The Seven Systems

Here is the map we use for that question.

Two of those systems, the master switch and central desire, sit entirely on the want side. They are also the two the standard script almost never checks. That is where a lot of the failures live.

What The Three Men Actually Needed

Read the three cases against the map and the answer changes.

The first man did not need a stronger amplifier. He needed the want side evaluated.

The second man did not need a prettier testosterone number. He needed someone to ask why a good number had not translated into desire.

The third man did not need to stop a metabolic drug that was helping him. He needed the sexual side effect treated as a pathway problem, not as a reason to abandon the metabolic win.

That is the workup. Not "which drug do we try next?" but "what was the failed drug supposed to fix?"

The fine print. Everything named in this series, including GLP-1 medications, PT-141, enclomiphene, and the vascular-repair peptides, is a prescription product, evaluated and dosed under physician supervision, and where compounded, dispensed by a licensed 503A pharmacy. Several are used off-label or are not FDA-approved finished products. Nothing here is a recommendation to start, stop, or change any medication on your own, and care is available only in select states.

If a medication did not work, do not stop at "try more." Ask what it was supposed to fix. Sometimes the failed drug is the clue that points you to the right system.

Kinetic Edge Health is a physician-led telehealth practice focused on longevity, metabolic optimization, and urological wellness. If a stack in this issue is relevant to you, book a strategy session.

Short-form dispatches on longevity, metabolic health, and men’s performance — from the founder of Kinetic Edge Health.

Telehealth practice. Prescription compounds and peptides require physician evaluation. Not available in all states.

kineticedgehealth.com · Cleveland, OH

© 2026 Kinetic Edge Health, Inc. · All rights reserved.

Not for you anymore?

Use the unsubscribe link below to stop future issues.